down arrow

Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
120.00
3.55 (3.05%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.46 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

118.50121.05

52 Week

92.25184.95
Valuation
Technical
Day's Volume

CASH

1.46 lacs (-53.86%) Volume

Shareholding (Dec 2024)

FII

13.51%

Held by 42 FIIs

DII

6.55%

Held by 3 DIIs

Promoter

35.10%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -0.09% and Operating profit at -3.73% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,264 Cr (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.43%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

9.17%

stock-summary
Price to Book

1.22

Revenue and Profits (1 Year):
Net Sales:
210 Cr
(Quarterly Results - Dec 2024)
Net Profit:
24 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.43%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-6.47%
0%
-6.47%
1 Year
4.48%
0.39%
4.87%
2 Years
63.53%
1.32%
64.85%
3 Years
37.69%
2.17%
39.86%
4 Years
18.4%
1.88%
20.28%
5 Years
18.05%
2.68%
20.73%

Latest dividend: 0.5 per share ex-dividend date: Jul-18-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-0.09%
EBIT Growth (5y)
-3.73%
EBIT to Interest (avg)
14.67
Debt to EBITDA (avg)
0.89
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.73
Tax Ratio
30.09%
Dividend Payout Ratio
6.94%
Pledged Shares
0
Institutional Holding
20.06%
ROCE (avg)
12.76%
ROE (avg)
9.43%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
33
Price to Book Value
1.22
EV to EBIT
10.42
EV to EBITDA
8.22
EV to Capital Employed
1.25
EV to Sales
1.36
PEG Ratio
13.82
Dividend Yield
0.43%
ROCE (Latest)
13.60%
ROE (Latest)
9.17%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 42 FIIs (13.51%)

Promoter with highest holding

Narsimha Shibroor Kamath (30.69%)

Highest Public shareholder

Arian Investment Limited (8.76%)

Individual Investors Holdings

32.93%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 4.83% vs -2.43% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -13.80% vs -1.18% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.42",
          "val2": "200.72",
          "chgp": "4.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.79",
          "val2": "43.69",
          "chgp": "-31.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.08",
          "val2": "2.12",
          "chgp": "-49.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.80",
          "val2": "27.61",
          "chgp": "-13.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.16%",
          "val2": "21.77%",
          "chgp": "-7.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 8.06% vs 2.86% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -21.11% vs 44.02% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "401.32",
          "val2": "371.40",
          "chgp": "8.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "75.81",
          "val2": "78.58",
          "chgp": "-3.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.36",
          "val2": "2.94",
          "chgp": "82.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "44.96",
          "val2": "56.99",
          "chgp": "-21.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.89%",
          "val2": "21.16%",
          "chgp": "-2.27%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.93% vs 0.94% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -18.72% vs 25.31% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "611.74",
          "val2": "572.12",
          "chgp": "6.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "105.60",
          "val2": "122.27",
          "chgp": "-13.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.44",
          "val2": "5.06",
          "chgp": "27.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "68.76",
          "val2": "84.60",
          "chgp": "-18.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.26%",
          "val2": "21.37%",
          "chgp": "-4.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 2.48% vs 0.55% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.48% vs 371.14% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "770.24",
          "val2": "751.59",
          "chgp": "2.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "150.62",
          "val2": "117.32",
          "chgp": "28.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.91",
          "val2": "10.36",
          "chgp": "-33.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-29.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "75.45",
          "val2": "70.86",
          "chgp": "6.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.55%",
          "val2": "15.61%",
          "chgp": "3.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
210.42
200.72
4.83%
Operating Profit (PBDIT) excl Other Income
29.79
43.69
-31.82%
Interest
1.08
2.12
-49.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23.80
27.61
-13.80%
Operating Profit Margin (Excl OI)
14.16%
21.77%
-7.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 4.83% vs -2.43% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -13.80% vs -1.18% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
401.32
371.40
8.06%
Operating Profit (PBDIT) excl Other Income
75.81
78.58
-3.53%
Interest
5.36
2.94
82.31%
Exceptional Items
0.00
0.00
Consolidate Net Profit
44.96
56.99
-21.11%
Operating Profit Margin (Excl OI)
18.89%
21.16%
-2.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 8.06% vs 2.86% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -21.11% vs 44.02% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
611.74
572.12
6.93%
Operating Profit (PBDIT) excl Other Income
105.60
122.27
-13.63%
Interest
6.44
5.06
27.27%
Exceptional Items
0.00
0.00
Consolidate Net Profit
68.76
84.60
-18.72%
Operating Profit Margin (Excl OI)
17.26%
21.37%
-4.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.93% vs 0.94% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -18.72% vs 25.31% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
770.24
751.59
2.48%
Operating Profit (PBDIT) excl Other Income
150.62
117.32
28.38%
Interest
6.91
10.36
-33.30%
Exceptional Items
-29.20
0.00
Consolidate Net Profit
75.45
70.86
6.48%
Operating Profit Margin (Excl OI)
19.55%
15.61%
3.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 2.48% vs 0.55% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 6.48% vs 371.14% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Bliss GVS Pharma Ltd stock-summary
stock-summary
Bliss GVS Pharma Ltd
Small Cap
Pharmaceuticals & Drugs
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006.
Company Coordinates stock-summary
Company Details
102 Hyde Park Sakivihar Road, Andheri East Mumbai Maharashtra : 400072
stock-summary
Tel: 91-22-42160000
stock-summary
http://www.blissgvs.com
stock-summary
info@blissgvs.com
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."